Report to PCWP/HCPWP from HMPC Herbal monographs, consultation of - - PowerPoint PPT Presentation

Classified as public by the European Medicines Agency

Report to PCWP/HCPWP from HMPC

Herbal monographs, consultation of patients and possible training sessions

Steffen Bager, HMPC member

Classified as public by the European Medicines Agency

Consulting patients on herbal medicinal products

• 5. MARTS 2020

2

‒ Already established consultation of ARSP’s ‒ Commenting draft monographs in December 2019:

• Rheum palmatum
• Rhamnus purshiana
• Thyme oil
• Tanacetum parthenium

Classified as public by the European Medicines Agency

Early experiences – how to increase involvement / knowledge

• 5. MARTS 2020

3

‒ Continue with the regular practice to consult patient representatives on draft HMPC documents (e.g. Herbal summaries for the public, draft monographs) ‒ Organise information session to raise understanding of different document functions (e.g. MO, AR, vs SmPC and labelling) – including the role of patients input ‒ Consult patient representatives for specific questions via EMA established network of patients, via PCWP/HCPWP ‒ Call for additional members to join ‘herbal patient group’

Classified as public by the European Medicines Agency

Følg os

• 5. MARTS 2020

4